Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

capture

NICE names new non-executive director

March 25, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, tim irish

The Department of Health has appointed Tim Irish as a non-executive director of the National Institute for Health and Care …
Appointment
Keytruda image

Merck’s Keytruda trial stopped early after beating BMS’ Yervoy on survival

March 25, 2015 Research and Development, Sales and Marketing BMS, Merck, Yervoy, ipilimumab, keytruda, pembrolizumab

A trial comparing two potential blockbuster cancer treatments has been stopped early, after Merck’s Keytruda beat BMS’ Yervoy in a …
News
Astrazeneca image

AstraZeneca and Harvard team up for diabetes research

March 25, 2015 Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic

AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …
News
timothy_wright_teva

Teva hires new business development head

March 25, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, timothy wright

Teva Pharmaceutical Industries has confirmed the appointment of Timothy Wright to its executive leadership team to head up business development, …
Appointment
Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015 Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …
News
FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …
News
Stefan Oschmann

Chief executive promotion at Merck KGaA

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive

Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
News
christa_wirthumer-hoche

EMA elects new vice-chair

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christa Wirthumer-Hoche, EMA

The European Medicines Agency has elected Dr Christa Wirthumer-Hoche, the head of the Austrian Medicines and Medical Devices Agency, as …
Appointment
steve_cottrell3

Maetrics announces new president

March 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maetrics, steve cottrell

Maetrics has confirmed that Steve Cottrell, previously its vice president of sales, will now assume the role of president at …
Appointment
Lilly image

Lilly and Hanmi enter immunological therapy pact

March 20, 2015 Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …
News
michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …
Appointment
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015 Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …
News
Herceptin image

Breast cancer treatment market booming

March 19, 2015 Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …
News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015 Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …
News
Teva image

Teva and Ignyta shake hands in oncology deal

March 19, 2015 Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026